AR022427A1 - Cetonas peptidil heterociclicas utiles como inhibidoras de la triptasa - Google Patents
Cetonas peptidil heterociclicas utiles como inhibidoras de la triptasaInfo
- Publication number
- AR022427A1 AR022427A1 ARP000100333A ARP000100333A AR022427A1 AR 022427 A1 AR022427 A1 AR 022427A1 AR P000100333 A ARP000100333 A AR P000100333A AR P000100333 A ARP000100333 A AR P000100333A AR 022427 A1 AR022427 A1 AR 022427A1
- Authority
- AR
- Argentina
- Prior art keywords
- inhibitors
- ketones
- heterociclicas
- peptidil
- triptase
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 150000002576 ketones Chemical class 0.000 title 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 206010039085 Rhinitis allergic Diseases 0.000 abstract 1
- 229940124639 Selective inhibitor Drugs 0.000 abstract 1
- 102000012479 Serine Proteases Human genes 0.000 abstract 1
- 108010022999 Serine Proteases Proteins 0.000 abstract 1
- 102000001400 Tryptase Human genes 0.000 abstract 1
- 108060005989 Tryptase Proteins 0.000 abstract 1
- 201000010105 allergic rhinitis Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 210000004969 inflammatory cell Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- -1 peptidyl heterocyclic ketones Chemical class 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11760299P | 1999-01-27 | 1999-01-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR022427A1 true AR022427A1 (es) | 2002-09-04 |
Family
ID=22373811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000100333A AR022427A1 (es) | 1999-01-27 | 2000-01-26 | Cetonas peptidil heterociclicas utiles como inhibidoras de la triptasa |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US6469036B1 (https=) |
| EP (1) | EP1147097A1 (https=) |
| JP (1) | JP2002535394A (https=) |
| KR (1) | KR20010110422A (https=) |
| CN (1) | CN1353701A (https=) |
| AR (1) | AR022427A1 (https=) |
| AU (1) | AU3208500A (https=) |
| BG (1) | BG105762A (https=) |
| BR (1) | BR0007778A (https=) |
| CA (1) | CA2361479A1 (https=) |
| CZ (1) | CZ20012722A3 (https=) |
| EA (1) | EA200100815A1 (https=) |
| EE (1) | EE200100391A (https=) |
| HK (1) | HK1038561A1 (https=) |
| HR (1) | HRP20010601A2 (https=) |
| HU (1) | HUP0201295A3 (https=) |
| IL (1) | IL144577A0 (https=) |
| NO (1) | NO20013666L (https=) |
| SK (1) | SK10742001A3 (https=) |
| TR (1) | TR200102766T2 (https=) |
| TW (1) | TWI229669B (https=) |
| WO (1) | WO2000044733A1 (https=) |
| YU (1) | YU61401A (https=) |
| ZA (1) | ZA200106995B (https=) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6346510B1 (en) | 1995-10-23 | 2002-02-12 | The Children's Medical Center Corporation | Therapeutic antiangiogenic endostatin compositions |
| DE60120661T2 (de) * | 2000-03-27 | 2007-07-05 | Applied Research Systems Ars Holding N.V. | Pharmazeutisch wirksame pyrrolidin-derivate als bax-inhibitoren |
| DK1268419T3 (da) * | 2000-03-27 | 2006-10-02 | Applied Research Systems | Farmaceutisk aktive pyrrolidinderivater som BAX-inhibitorer |
| US6960597B2 (en) * | 2000-06-30 | 2005-11-01 | Orth-Mcneil Pharmaceutical, Inc. | Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists |
| US6589978B2 (en) * | 2000-06-30 | 2003-07-08 | Hoffman-La Roche Inc. | 1-sulfonyl pyrrolidine derivatives |
| US6797461B2 (en) * | 2000-10-27 | 2004-09-28 | Promega Corporation | Tryptase substrates and assay for tryptase activity using same |
| CA2433713A1 (en) * | 2001-01-05 | 2002-07-18 | Kyowa Hakko Kogyo Co., Ltd. | Preventives for arthritis |
| JP2004518688A (ja) | 2001-01-30 | 2004-06-24 | ブリストル−マイヤーズ スクイブ カンパニー | ファクターＸａ阻害剤のスルホンアミドラクタムおよびその方法 |
| GB0103765D0 (en) * | 2001-02-15 | 2001-04-04 | Affitech As | Assay |
| EP1455765A2 (en) * | 2001-12-13 | 2004-09-15 | Kowa Company Ltd. | Use of protease-activated receptor-2 inhibitor in the manufacture of a medicament for treating delayed hypersensitivity |
| WO2003101381A2 (en) * | 2002-05-29 | 2003-12-11 | Merck & Co., Inc. | 1,2 diamido cycloalkyl sodium channel blockers |
| DE10249304B4 (de) * | 2002-10-22 | 2006-09-28 | Cytec Surface Specialties Germany Gmbh & Co. Kg | Wäßrige Beschichtungsmittel |
| US7205384B2 (en) | 2003-08-05 | 2007-04-17 | Ortho-Mcneil Pharmaceutical Inc. | Process for preparing peptidyl heterocyclic ketone derivatives |
| US20050176755A1 (en) * | 2003-10-31 | 2005-08-11 | Dyatkin Alexey B. | Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists |
| ATE371649T1 (de) * | 2004-02-10 | 2007-09-15 | Janssen Pharmaceutica Nv | Pyridazinonharnstoffe als antagonisten von a4- integrinen |
| JP2008510726A (ja) * | 2004-08-20 | 2008-04-10 | エントレメッド インコーポレイテッド | プロテイナーゼ活性化受容体アンタゴニストを含む組成物および方法 |
| GB0507577D0 (en) * | 2005-04-14 | 2005-05-18 | Novartis Ag | Organic compounds |
| JP5270538B2 (ja) * | 2006-05-23 | 2013-08-21 | アイアールエム・リミテッド・ライアビリティ・カンパニー | チャネル活性化プロテアーゼ阻害剤としての化合物および組成物 |
| CA2651762A1 (en) * | 2006-05-23 | 2007-11-29 | Irm Llc | Compounds and compositions as channel activating protease inhibitors |
| KR101131238B1 (ko) | 2007-02-09 | 2012-03-30 | 아이알엠 엘엘씨 | 채널 활성화 프로테아제 억제제로서의 화합물 및 조성물 |
| AU2008214217B2 (en) * | 2007-02-09 | 2011-10-13 | Irm Llc | Compounds and compositions as channel activating protease inhibitors |
| MX2009008493A (es) * | 2007-02-09 | 2009-08-20 | Irm Llc | Compuestos y composiciones como inhibidores de la proteasa activadora de canal. |
| ES2351323B1 (es) * | 2009-06-26 | 2011-10-05 | Institut Univ. De Ciència I Tecnologia, S.A. | Bibliotecas de n-fenil-1-sulfonil-2-pirrolidinacarboxamidas para el descubrimiento de farmacos. |
| EP2714716B1 (en) | 2011-06-02 | 2018-04-11 | Socpra Sciences Santé Et Humaines S.E.C. | Matriptase inhibitors and uses thereof against orthomyxoviridae infections |
| CN103145598B (zh) * | 2011-12-07 | 2014-10-15 | 北京京卫顺康医药科技发展有限公司 | 一种奥沙西罗晶体及含有该晶体的组合物 |
| HRP20181197T1 (hr) * | 2013-10-29 | 2018-11-30 | Biomarin Pharmaceutical Inc. | Derivati n-(1-hidroksi-3-(pirolidinil)propan-2-il)pirolidin-3-karboksamida kao inhibitori glukozilceramid sintaze |
| PT3204352T (pt) | 2014-10-06 | 2020-09-23 | Cortexyme Inc | Inibidores de lisina-gingipaína |
| WO2016144654A1 (en) * | 2015-03-09 | 2016-09-15 | Washington University | Inhibitors of growth factor activation enzymes |
| CA3004095A1 (en) | 2015-11-09 | 2017-05-18 | Cortexyme, Inc. | Inhibitors of arginine gingipain |
| ES2992410T3 (es) | 2016-09-16 | 2024-12-12 | Lighthouse Pharmaceuticals Inc | Inhibidores cetónicos de la lisina gingipaína |
| CN110944637A (zh) * | 2017-05-10 | 2020-03-31 | 库特克希米公司 | 氨基吡啶化合物及其制备方法和使用方法 |
| EP4159211A4 (en) * | 2021-07-15 | 2024-10-30 | National Center for Global Health and Medicine | ASSOCIATED WITH PHYSIOLOGICAL ACTIVITY SUCH AS ANTIVIRAL ACTIVITY |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5525623A (en) * | 1993-03-12 | 1996-06-11 | Arris Pharmaceutical Corporation | Compositions and methods for the treatment of immunomediated inflammatory disorders |
| JPH0820597A (ja) | 1994-07-07 | 1996-01-23 | Meiji Seika Kaisha Ltd | トロンビン阻害作用を有する複素環カルボニル化合物 |
| JPH10513151A (ja) | 1994-12-22 | 1998-12-15 | バイオケム ファーマ インコーポレイテッド | トロンビン阻害剤としての複素環式ケトアルギニンペプチド |
| WO1996019483A1 (en) | 1994-12-22 | 1996-06-27 | Biochem Pharma Inc. | Low molecular weight bicyclic thrombin inhibitors |
| WO1996030396A1 (en) | 1995-03-24 | 1996-10-03 | Molecumetics Ltd. | β-SHEET MIMETICS AND USE THEREOF AS PROTEASE INHIBITORS |
| EP0815123B1 (en) | 1995-03-24 | 2001-10-04 | Molecumetics, Ltd. | Beta-sheet mimetics and use thereof as protease inhibitors |
| GB9510264D0 (en) | 1995-05-22 | 1995-07-19 | Iaf Biochem Int | Low molecular weight bicyclic-urea type thrombin inhibitors |
| US5827860A (en) * | 1995-06-07 | 1998-10-27 | Ortho Pharmaceutical Corporation | Peptidyl heterocycles useful in the treatment of thrombin related disorders |
| US5827866A (en) | 1995-06-07 | 1998-10-27 | Ortho Pharmaceutical Corporation | Peptidyl heterocycles useful in the treatment of thrombin related disorders |
| US5523308A (en) | 1995-06-07 | 1996-06-04 | Costanzo; Michael J. | Peptidyl heterocycles useful in the treatment of thrombin related disorders |
| US6069130A (en) | 1995-06-07 | 2000-05-30 | Cor Therapeutics, Inc. | Ketoheterocyclic inhibitors of factor Xa |
| IL119466A (en) * | 1995-11-03 | 2001-08-26 | Akzo Nobel Nv | Thrombin inhibitors, their preparation and pharmaceutical compositions containing them |
| CA2262900A1 (en) | 1996-08-05 | 1998-02-12 | Molecumetics Ltd. | Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| AU4172397A (en) | 1996-09-06 | 1998-03-26 | Biochem Pharma Inc. | Lactam inhibitors of thrombin |
| US5827886A (en) * | 1997-05-07 | 1998-10-27 | Thione International, Inc. | Composition for relief of arthritis-induced symptoms |
| US8039026B1 (en) | 1997-07-28 | 2011-10-18 | Johnson & Johnson Consumer Companies, Inc | Methods for treating skin pigmentation |
| WO1999026925A1 (en) | 1997-11-26 | 1999-06-03 | Yoshitomi Pharmaceutical Industries, Ltd. | Tryptase inhibitors comprising heterocyclic amide compounds |
| CA2314899A1 (en) | 1997-12-16 | 1999-06-24 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for regulating phagocytosis and icam-1 expression |
-
2000
- 2000-01-13 TR TR2001/02766T patent/TR200102766T2/xx unknown
- 2000-01-13 EE EEP200100391A patent/EE200100391A/xx unknown
- 2000-01-13 YU YU61401A patent/YU61401A/sh unknown
- 2000-01-13 CN CN00805510A patent/CN1353701A/zh active Pending
- 2000-01-13 IL IL14457700A patent/IL144577A0/xx unknown
- 2000-01-13 AU AU32085/00A patent/AU3208500A/en not_active Abandoned
- 2000-01-13 WO PCT/US2000/000883 patent/WO2000044733A1/en not_active Ceased
- 2000-01-13 CA CA002361479A patent/CA2361479A1/en not_active Abandoned
- 2000-01-13 EP EP00909902A patent/EP1147097A1/en not_active Withdrawn
- 2000-01-13 EA EA200100815A patent/EA200100815A1/ru unknown
- 2000-01-13 SK SK1074-2001A patent/SK10742001A3/sk unknown
- 2000-01-13 KR KR1020017009542A patent/KR20010110422A/ko not_active Ceased
- 2000-01-13 CZ CZ20012722A patent/CZ20012722A3/cs unknown
- 2000-01-13 HK HK02100110.3A patent/HK1038561A1/zh unknown
- 2000-01-13 HR HR20010601A patent/HRP20010601A2/hr not_active Application Discontinuation
- 2000-01-13 US US09/482,802 patent/US6469036B1/en not_active Expired - Lifetime
- 2000-01-13 JP JP2000595989A patent/JP2002535394A/ja not_active Withdrawn
- 2000-01-13 HU HU0201295A patent/HUP0201295A3/hu unknown
- 2000-01-13 BR BR0007778-0A patent/BR0007778A/pt not_active IP Right Cessation
- 2000-01-26 AR ARP000100333A patent/AR022427A1/es unknown
- 2000-02-24 TW TW089101335A patent/TWI229669B/zh not_active IP Right Cessation
-
2001
- 2001-07-26 NO NO20013666A patent/NO20013666L/no not_active Application Discontinuation
- 2001-08-01 BG BG105762A patent/BG105762A/xx unknown
- 2001-08-23 ZA ZA200106995A patent/ZA200106995B/en unknown
-
2002
- 2002-07-25 US US10/205,355 patent/US7132418B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200106995B (en) | 2002-11-25 |
| HK1038561A1 (zh) | 2002-03-22 |
| JP2002535394A (ja) | 2002-10-22 |
| EP1147097A1 (en) | 2001-10-24 |
| US7132418B2 (en) | 2006-11-07 |
| WO2000044733A1 (en) | 2000-08-03 |
| IL144577A0 (en) | 2002-05-23 |
| HUP0201295A3 (en) | 2002-10-28 |
| KR20010110422A (ko) | 2001-12-13 |
| NO20013666D0 (no) | 2001-07-26 |
| SK10742001A3 (sk) | 2002-08-06 |
| EE200100391A (et) | 2002-10-15 |
| BR0007778A (pt) | 2002-06-04 |
| CN1353701A (zh) | 2002-06-12 |
| TR200102766T2 (tr) | 2001-12-21 |
| HUP0201295A2 (en) | 2002-09-28 |
| YU61401A (sh) | 2005-07-19 |
| HRP20010601A2 (en) | 2002-08-31 |
| NO20013666L (no) | 2001-09-26 |
| US6469036B1 (en) | 2002-10-22 |
| EA200100815A1 (ru) | 2002-08-29 |
| CA2361479A1 (en) | 2000-08-03 |
| BG105762A (en) | 2002-03-29 |
| CZ20012722A3 (cs) | 2002-08-14 |
| TWI229669B (en) | 2005-03-21 |
| AU3208500A (en) | 2000-08-18 |
| US20030008829A1 (en) | 2003-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR022427A1 (es) | Cetonas peptidil heterociclicas utiles como inhibidoras de la triptasa | |
| UY27774A1 (es) | Inhibidores de metaloproteinas de triaril-oxi-aril-espiropirimidina-2,4,6-triona | |
| SV2004001414A (es) | Inhibidores del factor xa y de otras proteasas de serina implicadas en la cascada de la coagulacion. pc20535 | |
| CR20120356A (es) | Nuevos compuestos heterocíclicos activos como inhibidores de beta-lactamasas | |
| ATE512163T1 (de) | Verabreichung von mitteln zur behandlung von entzündungen | |
| DE60325498D1 (de) | 1-acyl-pyrrolidin-derivate für die behandlung von viralen infektionen | |
| ATE388708T1 (de) | Piperazinderivate und anwendungsverfahren | |
| UY26889A1 (es) | Compuestos farmacéuticos | |
| PE20030061A1 (es) | 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4 | |
| ECSP055844A (es) | Nuevos compuestos triciclicos | |
| DE60220385D1 (de) | Benzimidazole zur behandlung sexueller fehlfunktionen | |
| NO20071805L (no) | Alkylidentetrahydronaftalenderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere. | |
| EP1611120A4 (en) | NEW METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
| ATE367380T1 (de) | Zur behandlung von zns-erkrankungen geeignete piperazinylchinolinderivate | |
| EP1905452A4 (en) | AGENT FOR THE PREVENTION OR TREATMENT OF GLAUCOMA | |
| DE60329326D1 (de) | Tace inhibitoren | |
| UY29239A1 (es) | Nuevos derivados de piridotienopirimidina | |
| ATE333872T1 (de) | Zusammensetzng auf diclofenac-basis für die topische behandlung von erkrankungen des oropharynx | |
| DE502005002176D1 (de) | Substituierte chinolone | |
| UY29240A1 (es) | Nuevos derivados de piridotienopirimidina | |
| EA200500326A1 (ru) | Применение ферментированного экстракта проростков пшеницы в качестве противовоспалительного агента | |
| ATE410166T1 (de) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin- derivate zur behandlung von unfruchtbarkeit | |
| ATE345135T1 (de) | Tropan-derivate mit dopamin-wiederaufnahme-hemmer-wirkung für die behandlung von ischämischen erkrankungen | |
| EA200800342A1 (ru) | ИНГИБИТОРЫ Glepp-1 ДЛЯ ЛЕЧЕНИЯ АУТОИММУННЫХ И/ИЛИ ВОСПАЛИТЕЛЬНЫХ РАССТРОЙСТВ | |
| NO20053247D0 (no) | Anvendelse av levocetirizin ved behandling av vedvarende allergisk rhinitt. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |